Altis Labs
AI software that uses clinical-trial imaging to measure treatment response and predict patient outcomes.
$25MSeries A
ParticipantActivity from announced rounds
AI software that uses clinical-trial imaging to measure treatment response and predict patient outcomes.
Provides AI-powered investment platform for institutional investors in private markets
Develops small molecule drugs for historically challenging drug targets